A Critical Perspective on the Role of Catheter Ablation in Management of Atrial Fibrillation

Canadian Journal of Cardiology

Volumn 29, Issue 10, 2013, Pages 1150-1157

  Wyse, D George ^a  

^a CALGARY HEALTH REGION   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; WARFARIN;

CARDIAC RESYNCHRONIZATION THERAPY; CARDIOEMBOLIC STROKE; CARDIOVASCULAR MORTALITY; CATHETER ABLATION; CONGESTIVE HEART FAILURE; ELECTROCARDIOGRAPHY MONITORING; HEART ATRIUM FIBRILLATION; HEART TAMPONADE; HUMAN; IATROGENIC DISEASE; PULMONARY VEIN ISOLATION; RADIOFREQUENCY ABLATION; REVIEW; SUPRAVENTRICULAR TACHYCARDIA; TRANSIENT ISCHEMIC ATTACK; VASCULAR ACCESS; VASCULAR DISEASE;

ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CATHETER ABLATION; ELECTROCARDIOGRAPHY; HUMANS; PULMONARY VEINS; RECURRENCE; TREATMENT OUTCOME;

EID: 84884590147     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2013.03.001     Document Type: Review

References (39)

1. Calkins H., Kuck K.H., Cappato R., et al. 2012 HRS/ECAS/EHRA expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. JInterven Cardiac Electrophysiol 2012, 33:171-257.
2. Calkins H. Catheter ablation to maintain sinus rhythm. Circulation 2012, 125:1439-1445.
3. Tung R., Buch E., Shivkumar K. Catheter ablation of atrial fibrillation. Circulation 2012, 126:223-229.
4. Cox J.L. Surgical treatment of atrial fibrillation: a review. Europace 2004, 5(supp1 1):S20-S29.
5. Haissaguerre M., Jais P., Shah D.C., et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. New Engl J Med 1998, 339:659-666.
6. Verma A., Macle L., Cox J., Skanes A.C., CCS Atrial Fibrillation Guidelines Committee Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: catheter ablation for atrial fibrillation/atrial flutter. Can J Cardiol 2011, 27:60-66.
7. Narayan S.M., Krummen D.E., Shivkumar K., Clopton P., Rappel W.J., Miller J.M. Treatment of atrial fibrillation by the ablation of localized sources. CONFIRM (Conventional ablation for atrial fibrillation with or without focal impulse and rotor modulation) trial. JAm Coll Cardiol 2012, 60:628-636.
8. Cappato R., Calkins H., Chen S.A., et al. Updated worldwide survey on methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythmia Electrophysiol 2010, 3:32-38.
9. Hussein A.A., Saliba W.I., Martin D.O., et al. Natural history and long-term outcomes of ablated atrial fibrillation. Circ Arrhythmia Electrophysiol 2011, 4:271-278.
10. 2 score and risk of very late recurrences after catheter ablation of paroxysmal atrial fibrillation. Heart Rhythm 2012, 9:1185-1191.
11. Packer DL. Catheter ablation vs. anti-arrhythmic drug therapy for atrial fibrillation trial (CABANA). NCT00911508. Available at: Accessed September 3,2012. http://clinicaltrials.gov/ct2/show/NCT00911508.
12. Benjamin E.J., Wolf P.A., D'Agostino R.B., Silbershatz H., Kannel W.B., Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998, 98:946-952.
13. Wyse D.G., Waldo A.L., DiMarco J.P., et al. Acomparison of rate control and rhythm control in patients with atrial fibrillation. New Engl J Med 2002, 347:1825-1833.
14. Roy D., Talajic M., Nattel S., et al. Rhythm control versus rate control for atrial fibrillation and heart failure. New Engl J Med 2008, 358:2667-2677.
15. Corley S.D., Epstein A.E., DiMarco J.P., et al. Relationships between sinus rhythm, and survival in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Circulation 2004, 109:1509-1513.
16. Talajic M., Khairy P., Levesque S., et al. Maintenance of sinus rhythm and survival in patients with heart failure and atrial fibrillation. JAm Coll Cardiol 2010, 55:1796-1802.
17. Pappone C., Rosanio S., Augello G., et al. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study. JAm Coll Cardiol 2003, 42:185-197.
18. Bunch T.J., Crandall B.G., Weiss J.P., et al. Patients treated with catheter ablation for atrial fibrillation have long-term rates of death, stroke and dementia similar to patients without atrial fibrillation. JCardiovasc Electrophysiol 2011, 22:839-845.
19. Dagres N., Varounis C., Flevari P., et al. Mortality after catheter ablation for atrial fibrillation compared with antiarrhythmic drug therapy: a meta-analysis of randomized trials. Am Heart J 2009, 158:15-20.
20. Connolly S.J., Ezekowitz M.D., Yusuf S., et al. Dabigatran versus warfarin in patients with atrial fibrillation. New Engl J Med 2009, 361:1139-1151.
21. Themistoclakis S., Corrado A., Marchlinski F.E., et al. The risk of thromboembolism and need for oral anticoagulation after successful atrial fibrillation ablation. JAm Coll Cardiol 2010, 55:735-743.
22. Hunter R.J., McCready J., Diab I., et al. Maintenance of sinus rhythm with an ablation strategy in patients with atrial fibrillation is associated with lower risk of stroke and death. Heart 2012, 98:48-53.
23. Reynolds M.R., Gunnarsson C.L., Hunter T.D., et al. Health outcomes with catheter ablation or antiarrhythmic drug therapy in atrial fibrillation: results of a propensity-matched analysis. Circ Cardiovasc Qual Outcomes 2012, 5:171-181.
24. Miller V.T., Rothrock J.F., Pearce L.A., Feinberg W.M., Hart R.G., Anderson D.C. Ischemic stroke in patients with atrial fibrillation: effect of aspirin according to stroke mechanism. Stroke Prevention in Atrial Fibrillation Investigators. Neurology 1993, 43:32-36.
25. Sherman D.G., Kim S.G., Boop B.S., et al. Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Arch Intern Med 2005, 165:1185-1191.
26. Daoud E.G., Glotzer T.V., Wyse D.G., et al. Temporal relationship of atrial tachyarrhythmias, cerebrovascular events, and systemic emboli based on stored device data: a subgroup analysis of TRENDS. Heart Rhythm 2011, 8:1416-1423.
27. Healey J.S., Connolly S.J., Gold M.R., et al. Subclinical atrial fibrillation and the risk of stroke. New Engl J Med 2012, 366:120-129.
28. Martinek M., Aichinger J., Nesser H.J., Ziegler P.D., Purerfellner H. New insights into long-term follow-up of atrial fibrillation: full disclosure by an implantable pacemaker device. JCardiovasc Electrophysiol 2007, 18:818-823.
29. University of Ottawa Heart Institute. Rate Versus Catheter Ablation Rhythm Control in Patients with Heart Failure and High-Burden Atrial Fibrillation (RAFT-AF). Available at: Accessed February 23,2013. http://clinicaltrials.gov/ct2/show/NCT01420393.
30. Hsu L.F., Jais P., Sanders P., et al. Catheter ablation for atrial fibrillation in congestive heart failure. New Engl J Med 2004, 351:2373-2383.
31. Khan M.N., Jais P., Cummings J., et al. Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. New Engl J Med 2008, 359:1778-1785.
32. Wilber D.J., Pappone C., Neuzil P., et al. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA 2010, 303:333-340.
33. Reynolds M.R., Walczak J., White S.A., Cohen D.J., Wilber D.J. Improvements in symptoms and quality of life in patients with paroxysmal atrial fibrillation treated with radiofrequency catheter ablation versus antiarrhythmic drugs. Circ Cardiovasc Qual Outcomes 2010, 3:615-623.
34. Hindricks G., Piorkowski C., Tanner H., et al. Perception of atrial fibrillation before and after radiofrequency catheter ablation: relevance of asymptomatic arrhythmia recurrence. Circulation 2005, 112:307-313.
35. Nakagawa H., Scherlag B.J., Patterson E., Ikeda A., Lockwood D., Jackman W.M. Pathophysiologic basis of autonomic ganglionated plexus ablation in patients with atrial fibrillation. Heart Rhythm 2009, 6(suppl. 12):S26-S34.
36. Nielsen J.C., Johannessen A., Raatikainen P., et al. Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation. New Engl J Med 2012, 367:1587-1595.
37. Population Health Research Institute. First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation Treatment (The RAAFT Study). Available at: Accessed February 3,2013. http://clinicaltrials.gov/ct2/show/NCT00392054.
38. Skanes A.C., Healey J.S., Cairns J.A., et al. Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control. Can J Cardiol 2012, 28:125-136.
39. Vergara G.R., Marrouche N.F. Tailored management of atrial fibrillation using a LGE-MRI based model: from the clinic to the electrophysiology laboratory. JCardiovasc Electrophysiology 2011, 22:481-487.